Estetrol: all 23 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Estetrol/Drospirenone to Reduce the Average Size of EndometriomasRecruitingNCT05837624Phase 4
- Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal WomenCompletedNCT06308614Phase 2Results posted
- Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)CompletedNCT04090957Phase 3Results posted
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada StudyCompletedNCT02817841Phase 3Results posted
- E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia StudyCompletedNCT02817828Phase 3Results posted
- Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrolCompletedNCT02720224Phase 1Results posted
- "Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation InhibitionCompletedNCT06396221Not applicable
- The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial PreparationCompletedNCT06324851Phase 4
- Effect of Estetrol Monohydrate (E4) on QTc IntervalCompletedNCT04819906Phase 1
- Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 InfectionStatus unknownNCT04801836Phase 2
- Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)CompletedNCT04209543Phase 3
- Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female VolunteersCompletedNCT03798197Phase 1
- Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) StudyCompletedNCT03512860Phase 1
- Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.CompletedNCT03361969Phase 2
- E4/DRSP Ovarian Function Inhibition StudyCompletedNCT03091595Phase 2
- "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"CompletedNCT02957630Phase 1/2
- Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female VolunteersCompletedNCT02852681Phase 1
- E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)CompletedNCT02834312Phase 2
- Evaluation of Safety and Efficacy of Estetrol in Healthy MenCompletedNCT02718378Phase 1
- Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast CancerCompletedNCT02718144Phase 1/2
- Feasibility Study Into the Contraceptive Effect of EstetrolCompletedNCT00563472Phase 2
- Preoperative Estetrol in Breast CancerCompletedNCT00464516Phase 2
- Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal WomenCompletedNCT00163033Phase 1